VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹45 Cr | ₹28 Cr | ₹27 Cr | ₹41 Cr | ₹62 Cr |
What is the latest Consolidated Net Profit of VENUS REMEDIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹45 Cr |
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹27 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹62 Cr |
How is Consolidated Net Profit of VENUS REMEDIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹45 Cr | 59.05 | |
| Mar2025 | ₹28 Cr | 7.25 | |
| Mar2024 | ₹27 Cr | -34.77 | |
| Mar2023 | ₹41 Cr | -34.07 | |
| Mar2022 | ₹62 Cr | - | |
Compare Consolidated Net Profit of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,391.1 Cr | 6.8% | 11.4% | 304.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 6.8% |
11.4% |
304.5% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses